New hope for Hard-to-Treat cancers: experimental drug MRG007 enters human testing
NCT ID NCT07066657
First seen Jan 05, 2026 · Last updated May 15, 2026 · Updated 20 times
Summary
This early-phase study tests an experimental drug called MRG007 in people with advanced solid tumors (like colorectal, gastric, or pancreatic cancer) that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. About 405 participants will take part across multiple centers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fred Hutchinson Cancer Center
NOT_YET_RECRUITINGSeattle, Washington, 98109, United States
-
Hunan Cancer Hospital
ACTIVE_NOT_RECRUITINGChangsha, Hunan, China
-
MD Anderson Cancer Center
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
-
NEXT Dallas
NOT_YET_RECRUITINGIrving, Texas, 75039, United States
-
NEXT Virginia
NOT_YET_RECRUITINGFairfax, Virginia, 22031, United States
-
Peking University Cancer Hospital
RECRUITINGBeijing, Beijing Municipality, 100142, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Renji Hospital Shanghai Jiaotong University School of Medicine
RECRUITINGShanghai, Shanghai Municipality, China
Contact
-
Sarah Cannon Research Institute
NOT_YET_RECRUITINGDenver, Colorado, 80218, United States
-
Sarah Cannon Research Institute
NOT_YET_RECRUITINGSarasota, Florida, 34232, United States
-
Sarah Cannon Research Institute
NOT_YET_RECRUITINGNashville, Tennessee, 37203, United States
-
UCSF
NOT_YET_RECRUITINGSan Francisco, California, 94158, United States
-
ULCA
NOT_YET_RECRUITINGLos Angeles, California, 90095, United States
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
ACTIVE_NOT_RECRUITINGWuhan, Hubei, China
-
University of Colorado
NOT_YET_RECRUITINGAurora, Colorado, 80010, United States
-
Zhongshan Hospital Fudan University
RECRUITINGShanghai, Shanghai Municipality, China
Contact
Conditions
Explore the condition pages connected to this study.